CD44 and cancer: Therefore, cell findings of EpCam+ and CD44+ CRC did not overlap which may not exclude the likelihood of the presence of cancer stem phenotype at a very small fraction, yet suggesting that the CD44+ CRC identified in the donors are different to CTC and CEB.